Literature DB >> 32804763

FDG PET/CT Findings in Biliary Papillomatosis.

Zhuolong Tu1, Yingnan Yang1, Jing Ruan2, Jinfu Tu1.   

Abstract

Biliary papillomatosis is a rare disease with high malignant potential. A 64-year-old woman underwent FDG PET/CT, which showed an intense FDG uptake in the location of an aggregated biliary papillomatosis with high-grade intraepithelial neoplasia/carcinoma in situ but did not show FDG uptake in the sporadic, small biliary papilloma. FDG PET/CT may be an effective method to identify the components of the malignant transformation of biliary papillomatosis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32804763      PMCID: PMC7469870          DOI: 10.1097/RLU.0000000000003243

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   10.782


A 64-year-old woman was admitted to our hospital because of recurrent cholangitis and obstructive jaundice for 2 months. Her previous major medical history included cholecystectomy because of a gallstone 7 years ago and left lateral lobectomy because of hepatolithiasis 4 years ago. Magnetic resonance cholangiopancreatography and enhanced MRI revealed dilatation of the biliary tract system and many stones in the intrahepatic bile duct. Multiple localized mural thickening in the intrahepatic and extrahepatic bile ducts suggested inflammatory changes; however, bile duct tumors remained to be excluded from the MRI. FDG PET/CT was recommended for further exploration. FDG PET/CT showed intense FDG uptake (SUVmax, 4.4) in multiple lesions on the wall of the left intrahepatic bile duct (red arrows) and common hepatic duct (green arrows), which connected and formed a strip shape on the MIP (blue arrow). This finding suggested biliary papillomatosis (A, MIP; B and C, axial PET; D and E, axial CT; and F and G, axial fusion). The patients underwent resection of grave hilar lesions and Roux-Y hepaticojejunostomy and biopsy of the right intrahepatic biliary papillary neoplasm. A large amount of gelatinous mucus and many hepatolithiasis were found in the dilated bile duct. There were numerous villous or papillary lesions on the biliary mucosa (A). The largest lesion that polymerized into several papillary neoplasms was approximately 4.8 × 1.7 cm on the intima of the common hepatic duct and left intrahepatic bile duct (B, within the blue circle), where intense FDG uptake was only shown on the PET images. Pathology confirmed biliary papillomatosis and high-grade intraepithelial neoplasia/carcinoma in situ at some areas of the hilar lesion (A, direct vision of the choledochoscopy; B, surgical specimens, scale bar 1 cm; C, pathology using hematoxylin-eosin staining at the original magnification of ×40; and D, at a magnification of ×400). Biliary papillomatosis or intraductal papillary neoplasm of the bile duct (IPNB) is a rare disorder with high malignant potential.[1-3] In patients with biliary papillomatosis, magnetic resonance cholangiopancreatography often shows irregular filling defects within the dilated bile duct, whereas CT and MRI demonstrate multiple intraductal soft tissue masses.[4,5] However, it is still a challenge to distinguish benign from malignant (invasive and noninvasive) biliary papillomatoses by conventional imaging techniques.[6-8] FDG PET/CT has been used to detect a single malignant intraductal papillary mucinous neoplasm of the bile ducts, which showed intense FDG uptake in the tumor.[9] Ikeno et al[10] reported that the preoperative 18F-FDG PET SUVmax in patients with invasive IPNB and papillary cholangiocarcinoma was significantly higher than that in patients with noninvasive IPNB. In the current case, FDG PET/CT showed intense FDG uptake in the location of aggregated biliary papillomatosis with high-grade intraepithelial neoplasia/carcinoma in situ but did not show FDG uptake in the sporadic, small biliary papilloma. We assume that FDG PET/CT may be an effective method to identify the components of the malignant transformation of biliary papillomatosis.
  10 in total

1.  FDG PET/CT findings in malignant intraductal papillary mucinous neoplasm of the bile ducts.

Authors:  Kentaro Takanami; Tomomichi Hiraide; Tomohiro Kaneta; Hiroki Hayashi; Michiaki Unno; Fumiyoshi Fujishima; Hiroshi Fukuda; Shogo Yamada; Shoki Takahashi
Journal:  Clin Nucl Med       Date:  2010-02       Impact factor: 7.794

2.  Recurrent cholangitis in a 65-year-old man. Biliary papillomatosis.

Authors:  M E Joosse; M E I Schipper; L Libbrecht; H R van Buuren; R A de Man
Journal:  Gut       Date:  2014-12-22       Impact factor: 23.059

3.  Biliary papillomatosis.

Authors:  Mathieu Struyve; Schalk Van Der Merwe
Journal:  Dig Endosc       Date:  2018-12-25       Impact factor: 7.559

4.  Usefulness of Preoperative 18F-FDG-PET in Detecting Invasive Intraductal Papillary Neoplasm of the Bile Duct.

Authors:  Yoshinobu Ikeno; Satoru Seo; Gen Yamamoto; Yuji Nakamoto; Yusuke Uemoto; Hiroaki Fuji; Kenji Yoshino; Tomoaki Yoh; Kojiro Taura; Shinji Uemoto
Journal:  Anticancer Res       Date:  2018-06       Impact factor: 2.480

5.  Morphological classification of intraductal papillary neoplasm of the bile duct.

Authors:  Shihong Ying; Mingliang Ying; Wenjie Liang; Zhaoming Wang; Qidong Wang; Feng Chen; Wenbo Xiao
Journal:  Eur Radiol       Date:  2017-11-14       Impact factor: 5.315

6.  Biliary papillomatosis with malignant transformation: A case report and review of the literature.

Authors:  Chichang Gu; Y E Lin; Haosheng Jin; Zhixiang Jian
Journal:  Oncol Lett       Date:  2015-09-08       Impact factor: 2.967

7.  Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth.

Authors:  Yubao Liu; Xiaomei Zhong; Lifen Yan; Junhui Zheng; Zaiyi Liu; Changhong Liang
Journal:  Eur Radiol       Date:  2015-02-26       Impact factor: 5.315

Review 8.  Biliary papillary neoplasm of the liver.

Authors:  Y Nakanuma; M Sasaki; A Ishikawa; W Tsui; T C Chen; S F Huang
Journal:  Histol Histopathol       Date:  2002       Impact factor: 2.303

9.  Clinicopathologic review of 58 patients with biliary papillomatosis.

Authors:  Sang Soo Lee; Myung-Hwan Kim; Sung Koo Lee; Se Jin Jang; Moon-Hee Song; Kyu-Pyo Kim; Hong Ja Kim; Dong-Wan Seo; Dong Eun Song; Eunsil Yu; Seung-Gyu Lee; Young Il Min
Journal:  Cancer       Date:  2004-02-15       Impact factor: 6.860

10.  Tumor recurrence after liver transplantation for diffuse biliary papillomatosis in the absence of invasive carcinoma.

Authors:  Óscar Caso Maestro; Iago Justo Alonso; Yolanda Rodríguez Gil; Alberto Marcacuzco Quinto; Jorge Calvo Pulido; Carlos Jiménez Romero
Journal:  Rev Esp Enferm Dig       Date:  2018-08       Impact factor: 2.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.